
FDA Panel Shoots Down Cytokinetics Bid for Second Heart Drug Approval

WASHINGTON — A panel of advisors to the Food and Drug Administration on Tuesday declined to recommend approval of a new heart drug created by biotech firm Cytokinetics, finding the benefits of the drug do not outweigh its risks.
The FDA is not required to follow the recommendations of its independent advisors, but the 8-3 vote strongly suggests omecamtiv mecarbil is likely to be rejected.
“We are disappointed there was not a greater consensus among committee members relating to the benefit-risk of omecamtiv mecarbil, and we maintain our conviction in the strength of evidence supporting its potential benefit for patients suffering from HFrEF,” said Robert I. Blum, Cytokinetics’ president and chief executive officer, in a written statement issued Tuesday night.
“We continue to believe omecamtiv mecarbil can be a valuable add-on therapy for patients with worsening heart failure who remain at high risk for heart failure events and hospitalization despite treatment with available guideline-directed medical therapy,” Blum said.
“We plan to engage constructively with FDA as it completes its review of the application for omecamtiv mecarbil.”
Omecamtiv mecarbil is an investigational, selective, small molecule cardiac myosin activator. If approved by the FDA, it would become the first therapy indicated for HFrEF that directly targets the mechanisms of the heart responsible for contraction — or its pumping function.
In The News
Health
Voting
Regulation
WASHINGTON — The Department of Energy this past week proposed a new energy conservation rule for battery chargers for consumer... Read More
WASHINGTON — The Department of Energy this past week proposed a new energy conservation rule for battery chargers for consumer products. A public meeting via webinar has been scheduled on Thursday, April 27, 2023, from 1:00 p.m. to 4:00 p.m. More information can be found here.... Read More
WASHINGTON — President Joe Biden is urging Congress to give the Federal Deposit Insurance Corporation more power to punish bank... Read More
WASHINGTON — President Joe Biden is urging Congress to give the Federal Deposit Insurance Corporation more power to punish bank executives whose institutions failed due their own mismanagement or excessive risk taking. Biden’s remarks, issued as a statement from the White House, come in the wake... Read More
ATCHAFALAYA NATIONAL WILDLIFE REFUGE, La. (AP) — Stacks of valves, networks of pipes and hulking, two-story-tall tanks litter parts of... Read More
ATCHAFALAYA NATIONAL WILDLIFE REFUGE, La. (AP) — Stacks of valves, networks of pipes and hulking, two-story-tall tanks litter parts of the swampy landscape of Louisiana’s Atchafalaya Basin, rusting relics of sites where oil wells were drilled in the 1970s, an unwanted legacy of the energy industry... Read More
WASHINGTON — For the first time, the Environmental Protection Agency is proposing federal limits on toxic “forever chemicals” in drinking... Read More
WASHINGTON — For the first time, the Environmental Protection Agency is proposing federal limits on toxic “forever chemicals” in drinking water, a move the Biden administration believes will prevent serious illness and death for thousands of Americans each year. PFAS, an abbreviation for perfluoroalkyl and polyfluoroalkyl... Read More
NEW YORK (AP) — President Joe Biden on Monday told U.S. residents the nation’s financial systems are sound, following the... Read More
NEW YORK (AP) — President Joe Biden on Monday told U.S. residents the nation’s financial systems are sound, following the swift and stunning collapse of two banks that prompted fears of a broader upheaval. “Americans can have confidence that the banking system is safe,” he said... Read More
WASHINGTON — Sens. Joe Manchin, D-W.Va., and Mike Braun, R-Ind., reintroduced a trio of bills Wednesday aimed at reforming how... Read More
WASHINGTON — Sens. Joe Manchin, D-W.Va., and Mike Braun, R-Ind., reintroduced a trio of bills Wednesday aimed at reforming how the Food and Drug Administration approves and manages opioid medications. “In the last year, more than 106,000 Americans and 1,400 West Virginians died from drug-related overdoses,”... Read More